[1]李宏文 综述,王 耸 霍 然 审校.血管内乳头状内皮细胞增生(马松瘤)的诊断与治疗进展[J].中国美容医学,2023,(4):198-201.
 LI Hongwen,WANG Song,HUO Ran.Progress of Diagnosis and Treatment for Intravascular Papillary Endothelial Hyperplasia(Masson’s Tumor)[J].Medical Aesthetics and Beauty,2023,(4):198-201.
点击复制

血管内乳头状内皮细胞增生(马松瘤)的诊断与治疗进展()
分享到:

《中国美容医学》[ISSN:1008-6445/CN:61-1347/R]

卷:
期数:
2023年4期
页码:
198-201
栏目:
出版日期:
2023-04-10

文章信息/Info

Title:
Progress of Diagnosis and Treatment for Intravascular Papillary Endothelial Hyperplasia(Masson’s Tumor)
文章编号:
1008-6455(2023)04-0198-04
作者:
李宏文1 综述王 耸1 霍 然12 审校
(1.山东大学附属省立医院整形美容外科 山东 济南 250021 ;2.山东第一医科大学附属省立医院整形美容外科 山东 济南 250021 )
Author(s):
LI Hongwen1 WANG Song1 HUO Ran12
(1.Department of Plastic and Cosmetic Surgery,Shandong Provincial Hospital,Cheeloo College of Medicine,Shandong University,Jinan 250021,Shandong,China; 2.Department of Plastic and Cosmetic Surgery,Shandong Provincial Hospital Affi liated to Shandong First Medical University,Jinan 250021,Shandong,China)
关键词:
血管内乳头状内皮细胞增生马松瘤诊断鉴别诊断治疗?/html>
Keywords:
intravascular papillary endothelial hyperplasia Massons Tumor diagnosis diff erential diagnosis treatment
分类号:
R543
文献标志码:
A
摘要:
血管内乳头状内皮细胞增生(Intravascular papillary endothelial hyperplasia,IPEH)是一种罕见的血管良性病 变,又称为马松瘤。IPEH表现为反应性血管内皮细胞乳头状增生,与血栓形成密切相关。超声和MRI是其主要影像学检查, 但是其最终的诊断需要进行病理学及免疫组织化学检查。目前普遍认为手术切除是治疗的首选方法,切除不彻底将导致病变 复发。本文对IPEH诊断与治疗的相关文献进行回顾总结,以期为临床IPEH的诊断及治疗提供帮助。
Abstract:
Intravascular papillary endothelial hyperplasia(IPEH), also called Masson’s Tumor, is a rare benign vascular lesion. IPEH is characterized by a reactive proliferation of endothelial cells associated with thrombosis. Ultrasound and MRI are the main imaging examinations,but the diagnosis of IPEH was confi rmed by biopsy pathology and immunohistochemistry. It is generally accepted that surgical excision is the fi rst choice of treatment. The incomplete excision would lead to recurrence of the lesion. In this paper, the diagnosis and treatment of IPEH were reviewed, in order to guide the clinical diagnosis and treatment of IPEH.
更新日期/Last Update: 2023-05-17